What Selective SIGIP is doing to stay ahead Investor Concern 20260511 RYTM Rhythm Pharmaceuticals tops Q4 2025 EPS estimates posts 458 percent yearoveryear revenue growth shares dip 109 percent RPRX Royalty posts Q4 2025 87 percent EPS beat and 51 percent YoY revenue gain shares edge down Is Empire ESRT Stock a Good Dividend Stock Slight Gain 20260420